Analyst Brief July 20, 2026

H.R. 6238 — NIH IMPROVE Act, as amended

Executive Summary

H.R. 6238, the NIH IMPROVE Act, formally codifies and authorizes funding for the IMPROVE Initiative within the National Institutes of Health (NIH). The bill aims to address the United States' high maternal mortality and severe maternal morbidity rates by advancing research, reducing health disparities, and evaluating community-based interventions. By authorizing $63.4 million annually from FY2026 to FY2030, the legislation provides statutory backing to an existing NIH program, protecting it from future administrative reprioritization and ensuring long-term focus on the biological, behavioral, and systemic factors affecting pregnant and postpartum women.

Arguments For

  • Addresses a highly visible public health crisis: the U.S. has one of the highest maternal mortality rates among developed nations, making this a strong bipartisan talking point.
  • Provides statutory certainty for researchers and community organizations relying on NIH grants, fostering long-term studies on maternal health disparities without fear of sudden administrative cuts.

Likely Supporters

March of DimesAmerican College of Obstetricians and Gynecologists (ACOG)Association of Maternal & Child Health Programs (AMCHP)

Arguments Against

  • Fiscal conservatives may object to the specific authorization of $317 million over five years, preferring to fund NIH out of general appropriations without earmarking specific initiatives.
  • Critics on the right might argue that the explicit focus on 'health disparities' and 'disproportionately affected women' is politically charged or duplicative of other HHS equity initiatives.

Likely Opponents

Heritage ActionClub for Growth

📋 Key Provisions

  • Codifies the 'IMPROVE Initiative' within the NIH to research and reduce preventable causes of maternal mortality and severe maternal morbidity.
  • Directs the NIH to target health disparities by implementing and evaluating community-based interventions for disproportionately affected populations.
  • Authorizes the NIH Director to award grants, contracts, and cooperative agreements to carry out the initiative.
  • Authorizes $63.4 million annually for fiscal years 2026 through 2030 to fund the program.
search Verification Guide BETA expand_more

Don't trust AI? Don't worry, neither do I. Verify the claims yourself.

Claim Analysis Page 3, Line 20

Directs the initiative to advance research to reduce preventable maternal mortality.

Verify Text

"reduce preventable causes of maternal"

Claim Analysis Page 4, Line 22

Grants the NIH Director authority to award grants and enter into contracts.

Verify Text

"The Director of NIH may"

Claim Analysis Page 5, Line 3

Authorizes $63.4 million annually for FY2026 through FY2030.

Verify Text

"$63,400,000 for each of fiscal years"